Auto Injection Technologies LLC has launched litigation over the portfolio that it received from Sanofi last September 2024. The Anjay Venture Partners LLC plaintiff has accused Bayer (2:25-cv-00374), GSK (2:25-cv-00373), Medtronic (2:25-cv-00375), Novo Nordisk (2:25-cv-00376), and Ypsomed (2:25-cv-00377) of infringing up to seven of the patents from that portfolio, each through the provision of certain inhalers and/or injection devices. The Eastern District of Texas cases have been assigned to District Judge Rodney Gilstrap, currently, by far, the top judge overseeing patent cases in the US.

Recorded assignments recently made public by the USPTO reveal batches of US patents, one generally related to multi-display devices and another to drug delivery devices, on the move, to entities tied to experienced monetization teams—teams that have apparently secured the backing of the same prominent litigation funder. One of those entities is already in litigation, over previously received patents from the same source, while the other appears headed in that direction.